- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Zejula
Total 70 results
-
Ivy Brain Tumor CenterGlaxoSmithKlineNot yet recruitingGlioblastoma | Brain Tumor | GBM | Brain Neoplasms, Adult, Malignant
-
Ibrahim Halil SahinGlaxoSmithKlineNot yet recruitingMMR-D/MSI-H Colorectal CancersUnited States
-
Korea University Anam HospitalTakeda; Korean Cancer Study GroupNot yet recruiting
-
Haider MahdiGlaxoSmithKline; Zenith EpigeneticsRecruitingOvarian Cancer | Recurrent Solid TumorsUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustNot yet recruitingOvarian Cancer RecurrentUnited Kingdom
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
University of California, San FranciscoGlaxoSmithKlineRecruitingMetastatic Solid Tumor | BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
UNICANCERCancer Research UK; National Cancer Institute, France; Servier; Pierre Fabre Medicament and other collaboratorsNot yet recruitingBiliary Tract NeoplasmsUnited Kingdom, France, Belgium
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineRecruitingPenile CarcinomaUnited States
-
University of OklahomaGlaxoSmithKlineRecruitingRecurrent Ovarian Carcinoma | Recurrent Endometrial Carcinoma | ARID1A Gene MutationUnited States
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingRecurrent Glioma | Low-grade Glioma | Glioma, Malignant | IDH2 Gene Mutation | IDH1 MutationUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalNot yet recruitingEndometrial Cancer | Uterine Neoplasm | Serous Adenocarcinoma
-
AGO Research GmbHGlaxoSmithKlineNot yet recruitingPrimary Peritoneal Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer
-
Nader SanaiGlaxoSmithKline; University of California, San Francisco; Barrow Neurological... and other collaboratorsRecruitingGlioma | Glioblastoma | Glioblastoma Multiforme | GBM | Glioma, Malignant | Glioblastoma Multiforme of BrainUnited States
-
University Health Network, TorontoGlaxoSmithKlineRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid CancerCanada
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingMetastatic Cancer | Central Nervous System CancerUnited States
-
Ling-Ying WuNot yet recruiting
-
Joseph Caster, Ph.D., M.D.GlaxoSmithKlineRecruitingRectal Neoplasms | Rectal Neoplasm MalignantUnited States
-
Massachusetts General HospitalUniversity of Pennsylvania; Duke University; Sibley Memorial HospitalRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...GlaxoSmithKlineRecruiting
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research...RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer | Deleterious PALB2 Gene Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene MutationUnited States
-
Xiaoxiang ChenRecruitingOvarian Cancer | PARP Inhibitor | Clinical MarkerChina
-
Ulrik LassenGlaxoSmithKline; Pfizer; Roche Pharma AGRecruitingNeoplasms | Cancer | Tumors | NeoplasiaDenmark
-
University Health Network, TorontoRecruitingEndometrial Carcinoma | P53 Mutation | Serous CarcinomaCanada
-
Northwell HealthTesaro, Inc.RecruitingEndometrial Cancer | Endometrial Carcinoma | Uterine Serous Carcinoma | Cancer of the Endometrium | Papillary Serous Endometrial CarcinomaUnited States
-
Marc Dall'Era, MDNational Cancer Institute (NCI); Janssen, LPRecruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Prostate Carcinoma | RAD51C Gene Mutation | BRIP1 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CDK12 Gene Mutation | CHEK1 Gene Mutation | DNA Damage Response Gene Mutation | DNA Repair Gene Mutation | FANCA Gene Mutation and other conditionsUnited States
-
Massachusetts General HospitalTesaro, Inc.RecruitingLung CancerUnited States
-
Hoffmann-La RocheRecruitingCancerUnited States, France, Korea, Republic of, Taiwan, Japan, Spain, Belgium, Brazil, Czechia, Romania, Thailand, Australia, Bulgaria, Canada, Chile, Denmark, Germany, Greece, Guatemala, Hungary, Latvia, Mexico, Norway, Poland, Slovakia, Swit... and more
-
Tesaro, Inc.RecruitingOvarian NeoplasmsSpain, United States, Canada
-
Tarveda TherapeuticsRecruitingNeoplasms | Carcinoma | Small Cell Lung Carcinoma | Gastric Cancer | Pancreatic Adenocarcinoma | Solid Tumor | Gastric Adenocarcinoma | Small-cell Lung Cancer | Advanced Cancer | Pancreatic Ductal Adenocarcinoma | Adenocarcinoma of the Pancreas | Endometrial Adenocarcinoma | Squamous Cell Carcinoma of the Penis | Gastroesophageal... and other conditionsUnited States
-
The Netherlands Cancer InstituteBristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaboratorsRecruitingCancer | Neoplasm | Tumors | NeoplasiaNetherlands
-
OHSU Knight Cancer InstituteEli Lilly and Company; GlaxoSmithKline; Oregon Health and Science UniversityActive, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
Tesaro, Inc.Completed
-
University College, LondonGlaxoSmithKlineWithdrawnRecurrent Glioblastoma
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological OncologyActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly, Germany
-
Trisha Wise-DraperGlaxoSmithKlineActive, not recruitingHead and Neck CancerUnited States
-
Tesaro, Inc.Active, not recruitingNeoplasms | Solid Tumor | Non Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticUnited States
-
Shadia Jalal, MDGlaxoSmithKline; Indiana University School of MedicineActive, not recruitingAdenocarcinoma | Gastric Cancer | Esophageal CancerUnited States
-
MedSIRGlaxoSmithKlineCompletedBreast Cancer | Breast Cancer MetastaticSpain
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
University of PennsylvaniaTesaro, Inc.; NovoCure Ltd.Active, not recruiting
-
CanariaBio Inc.Veristat, LLCActive, not recruitingPeritoneal Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Epithelial Cancer of Ovary | Recurrent Epithelial Ovarian Cancer | Recurrent Carcinoma of Ovary | Adenocarcinoma of OvaryUnited States
-
University Hospital Southampton NHS Foundation...British Lung Foundation; University of SouthamptonActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
Byondis B.V.CompletedSolid TumorUnited Kingdom, Belgium, Netherlands
-
Tempus AIGlaxoSmithKlineActive, not recruitingMelanoma | Head and Neck Cancer | Pancreatic Cancer | Esophageal Cancer | Solid Tumor | Metastatic Cancer | Endometrial Cancer | Urologic Cancer | Breast Tumor | Locally Advanced Solid Tumor | Lung Tumor | Colon Tumor, MalignantUnited States
-
Artios Pharma LtdActive, not recruitingBreast Cancer | Metastatic Cancer | Advanced CancerUnited States, United Kingdom
-
The University of Hong KongCompletedOvarian CancerHong Kong
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States